
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Sexually transmitted diseases (STDs), bronchitis, pneumonia, infections of the lungs, sinuses, skin, throat, and reproductive organs are only a few of the bacterial infections that are treated with azithromycin.
Disseminated Mycobacterium avium complex (MAC) infection, a form of lung infection that frequently affects patients with human immunodeficiency virus (HIV), is another condition that azithromycin is used to treat or prevent.
The drug azithromycin belongs to the group of drugs known as macrolide antibiotics. It acts by preventing bacterial development.
Azithromycin is available as a tablet, an oral suspension (liquid), and an extended-release (long-acting) suspension (liquid). It is typical to take the tablets and suspension of Zithromax with or without food.
Tablets of azithromycin are typically given once weekly with or without food when being used to prevent disseminated MAC infection.
Numerous bacterial infections can be treated with azithromycin. Antibiotics of the macrolide class are it. It acts by preventing bacterial development. For viral infections, this drug is ineffective. (such as the common cold, flu). Any antibiotic's effectiveness may be reduced by unnecessary or improper use.
The Global AzithromycinMarket accountedfor $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Azithromycin is an antibiotic drug used to treat a variety of bacterial infections. It is marketed under the trade names Zithromax (in oral form) and Azasite (as an eye drop).
This covers pneumonia, traveller's diarrhoea, strep throat, middle ear infections, and a few other intestinal ailments.It might be used for malaria along with other drugs.It may be ingested or administered intravenously.
Nausea, vomiting, diarrhoea, and upset stomach are typical side effects.It is possible to experience an allergic reaction, such as anaphylaxis, QT prolongation, or a specific type of diarrhoea brought on by Clostridium difficile.There has been no evidence of danger from using it while pregnant.
Although its safety during breastfeeding has not been established, it is probably safe. An antibiotic known as an azalide, or macrolide, is azithromycin.It functions by reducing protein synthesis, which prevents bacterial growth.
The antibacterial action of azithromycin is shallow but somewhat wide. Some Gram-positive bacteria, some Gram-negative bacteria, and many unusual bacteria are all inhibited by it.
Through the reduction of inflammatory processes, azithromycin appears to be useful in the treatment of chronic obstructive pulmonary disease.
Additionally, this technique may be helpful in treating sinusitis and asthma.It is thought that azithromycin works by reducing immunological responses that may otherwise contribute to inflammation of the airways.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |